Our vision

ISNS is recognized worldwide for its contributions to the detection of neonatal conditions and the prevention of their adverse outcomes through excellence in neonatal screening.

Our mission

To enhance the quality of neonatal screening and medical services through dissemination of information, guidelines and best practices that benefit all family members and their babies by helping to ensure protection of babies from life-quality threatening conditions, such as phenylketonuria, congenital hypothyroidism, severe combined immunodeficiency, cystic fibrosis, hemoglobinopathies  and many others.

Welcome!

Welcome to the website of the International Society for Neonatal Screening (ISNS).
This society is aiming to advance screening for neonatal and infant sicknesses and disorders, worldwide.
ISNS has around 470 members in more than 70 different countries. Most members have a professional (para)medical background but a few are involved in parents’ or patients’ organisations.
For more information about ISNS visit the ISNS-Info section (see above).
ISNS welcomes new members who have demonstrated an active interest in neonatal screening.

Worldwide members

The location of members worldwide as of Jan. 1, 2017, is shown in the picture on the right. Countries/states with at least one member are shown in blue, others in grey.

How do I become a member?

Please read this  and subsequently click on the button “Member subscribe”

Why should I join as a member?

As a member you are entitled to see the privileged pages containing specific news items, a monthly neonatal screening literature service and a discount to ISNS-related conferences. Under certain conditions you may apply for travel grants to such conferences. Having access to the on line membership directory you have easier access to other members sharing specific interests.

Haematologic disorders: what are the ethical considerations concerning genomic testing?

An article from the journal of the American Society of Hematology describes the ethical challenges related to genomic testing use for haematologic disorders. It shows that challenges...

Read more
Newborn Screening Connect Registry (NBS Connect): beneficial for clinicians and patients?

The Orphanet Journal of Rare Diseases published...

Read more
Public Health: New sequencing in Genomic Medicine

In the American Academy of Pediatrics an article emphasises the value of genomic sequencing technology,...

Read more